Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TAK1-dependent signaling requires functional interaction with TAB2/TAB3.

Arnaud Besse1, Betty Lamothe, Alejandro D Campos

  • 1Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

The Journal of Biological Chemistry
|December 13, 2006
PubMed
Summary

The interaction between TAB2/TAB3 and TAK1 is essential for activating key signaling pathways like IL-1, TNF, and RANKL. This study identifies the specific binding domain crucial for TAK1 kinase activation and downstream signaling events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A STAT3/integrin axis accelerates pancreatic cancer initiation and progression.

Cell reports·2025
Same author

A phase 2 study of itacitinib alone or in combination with low-dose ruxolitinib in patients with myelofibrosis.

Leukemia research·2025
Same author

Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton's tyrosine kinase expression levels.

Blood cancer journal·2024
Same author

PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections.

Science translational medicine·2024
Same author

Metastasis is a highly stressful process.

Cancer metastasis reviews·2020
Same author

Bi-allelic HPDL Variants Cause a Neurodegenerative Disease Ranging from Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia.

American journal of human genetics·2020

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Immunology

Background:

  • Transforming growth factor beta-activated kinase 1 (TAK1) is a MAPKKK family member involved in TGF-beta signaling.
  • Emerging evidence links TAK1 to interleukin (IL)-1 and tumor necrosis factor (TNF) pathways.
  • TAB2 and TAB3 adaptors link TAK1 to TRAFs, but their role in TAK1 activation is unclear.

Purpose of the Study:

  • Characterize the TAB2/TAB3-binding domain in TAK1.
  • Determine if TAB2/TAB3 interaction is required for IL-1, TNF, and RANKL signaling.
  • Investigate the role of this interaction in IKK and MAPK pathway activation.

Main Methods:

  • Deletion mapping experiments to identify binding domains.
  • Utilized green fluorescent protein (GFP) fusion protein (TAK1-C100) to disrupt interactions.

Related Experiment Videos

  • Assessed kinase phosphorylation and pathway activation (IKK, MAPK).
  • Monitored NFATc1 nuclear accumulation and osteoclast differentiation.

    • Main Results:

    • The TAB2/TAB3 binding motif is within the C-terminal 100 residues of TAK1 (residues 479-553).
    • TAK1-C100 abolished TAB2/TAB3 interaction, TAK1 phosphorylation, and IL-1, TNF, RANKL-induced IKK/MAPK activation.
    • TAK1-C100 blocked RANKL-induced NFATc1 nuclear accumulation and osteoclast differentiation.

    Conclusions:

    • The interaction between TAB2/TAB3 and TAK1 is critical for activating IL-1, TNF, and RANKL signaling pathways.
    • This interaction is necessary for TAK1 kinase activation and subsequent downstream signaling.
    • Targeting the TAB2/TAB3-TAK1 interaction could modulate inflammatory and immune responses.